Illegal vape flavors, surge in child GLP-1 use, and rural hospital merger wave highlighted
New unauthorized vape flavors appear in Ohio, pediatric GLP-1 prescriptions have risen sharply, insurance gaps delay access to newly approved drugs, and rural hospitals are pursuing mergers to offset Medicaid cuts.
In Ohio, Vuse Pro marketed new fruity and mint vape flavors despite the products not yet being cleared by the FDA, raising concerns about lax enforcement. Research published in Pediatrics shows a dramatic increase in GLP-1 weight-loss medication use among children without diabetes, climbing from 0.3% to 9.3% between 2019 and mid-2026, with higher rates among girls, older children, and wealthier areas. After a breakthrough pancreatic cancer drug was approved, early-access programs closed while insurers scrambled to provide coverage, leaving patients like Kelsey Solano to rely on a GoFundMe for a week’s supply.
Rural hospitals, anticipating reduced Medicaid reimbursements, are accelerating mergers with larger systems, a trend that regulators fear could raise prices. Additional findings highlighted 1.66 million deaths worldwide from secondhand smoke in 2023 and a medical student’s account of pervasive anti-fat bias in clinical training.
Why it matters
The story shows how regulatory gaps, rising drug use in children, and financial strains threaten public health and healthcare access.
In this story
